US Stock MarketDetailed Quotes

Immunovant (IMVT)

Watchlist
  • 26.000
  • -1.350-4.94%
Close Jan 15 16:00 ET
  • 26.380
  • +0.380+1.46%
Post 18:58 ET
5.24BMarket Cap-9.22P/E (TTM)

Immunovant (IMVT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
13.84%131.76M
34.94%127.22M
62.15%438.15M
40.73%113.83M
85.70%114.3M
87.29%115.74M
42.90%94.28M
29.74%270.21M
25.86%80.88M
13.93%61.55M
Selling and administrative expenses
-5.19%17.51M
38.37%26.02M
34.84%77.24M
36.10%20.17M
49.69%19.78M
33.45%18.47M
22.11%18.81M
19.29%57.28M
19.33%14.82M
12.23%13.22M
-General and administrative expense
-5.19%17.51M
38.37%26.02M
34.84%77.24M
36.10%20.17M
49.69%19.78M
33.45%18.47M
22.11%18.81M
19.29%57.28M
19.33%14.82M
12.23%13.22M
Research and development costs
17.45%114.25M
34.09%101.2M
69.50%360.92M
41.78%93.65M
95.54%94.52M
102.82%97.27M
49.23%75.47M
32.87%212.93M
27.43%66.06M
14.40%48.34M
Operating profit
-13.84%-131.76M
-34.94%-127.22M
-62.15%-438.15M
-40.73%-113.83M
-85.70%-114.3M
-87.29%-115.74M
-42.90%-94.28M
-29.74%-270.21M
-25.86%-80.88M
-13.93%-61.55M
Net non-operating interest income expense
-7.72%5.6M
-11.74%6.34M
-0.87%24.73M
-17.79%6.89M
-48.62%4.59M
70.02%6.07M
76.63%7.18M
229.22%24.95M
140.78%8.38M
203.43%8.93M
Non-operating interest income
-7.72%5.6M
-11.74%6.34M
-0.87%24.73M
-17.79%6.89M
-48.62%4.59M
70.02%6.07M
76.63%7.18M
229.22%24.95M
140.78%8.38M
203.43%8.93M
Other net income (expense)
-60.25%250K
4,139.29%1.19M
103.49%471K
141.40%1.07M
-214.99%-1.26M
3,045.00%629K
100.23%28K
-31.75%-13.51M
-826.69%-2.59M
109.31%1.09M
Special income (charges)
----
----
--0
--0
--0
--0
--0
-25.00%-12.5M
--0
--0
-Less:Restructuring and merger&acquisition
----
----
--0
--0
--0
--0
--0
25.00%12.5M
--0
--0
-Less:Other special charges
----
----
----
----
----
----
----
25.00%12.5M
--0
----
Other non- operating income (expenses)
-60.25%250K
4,139.29%1.19M
146.73%471K
141.40%1.07M
-214.99%-1.26M
3,045.00%629K
-93.97%28K
-298.42%-1.01M
-826.69%-2.59M
162.27%1.09M
Income before tax
-15.47%-125.91M
-37.47%-119.7M
-59.58%-412.95M
-40.99%-105.87M
-115.37%-110.97M
-87.33%-109.04M
-17.75%-87.07M
-22.67%-258.77M
-24.27%-75.09M
18.00%-51.53M
Income tax
661.54%594K
1,085.71%913K
57.14%891K
151.29%583K
240.74%152K
-82.82%78K
800.00%77K
6,200.00%567K
123.41%232K
-127.91%-108K
Net income
-15.93%-126.5M
-38.40%-120.61M
-59.58%-413.84M
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-22.93%-259.34M
-26.73%-75.32M
18.68%-51.42M
Net income continuous Operations
-15.93%-126.5M
-38.40%-120.61M
-59.58%-413.84M
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-22.93%-259.34M
-26.73%-75.32M
18.68%-51.42M
Minority interest income
Net income attributable to the parent company
-15.93%-126.5M
-38.40%-120.61M
-59.58%-413.84M
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-22.93%-259.34M
-26.73%-75.32M
18.68%-51.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-15.93%-126.5M
-38.40%-120.61M
-59.58%-413.84M
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-22.93%-259.34M
-26.73%-75.32M
18.68%-51.42M
Basic earnings per share
1.35%-0.73
-18.33%-0.71
-45.21%-2.73
-23.08%-0.64
-111.11%-0.76
-64.44%-0.74
-5.26%-0.6
-9.94%-1.88
-13.04%-0.52
26.53%-0.36
Diluted earnings per share
1.35%-0.73
-18.33%-0.71
-45.21%-2.73
-23.08%-0.64
-111.11%-0.76
-64.44%-0.74
-5.26%-0.6
-9.94%-1.88
-13.04%-0.52
26.53%-0.36
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 13.84%131.76M34.94%127.22M62.15%438.15M40.73%113.83M85.70%114.3M87.29%115.74M42.90%94.28M29.74%270.21M25.86%80.88M13.93%61.55M
Selling and administrative expenses -5.19%17.51M38.37%26.02M34.84%77.24M36.10%20.17M49.69%19.78M33.45%18.47M22.11%18.81M19.29%57.28M19.33%14.82M12.23%13.22M
-General and administrative expense -5.19%17.51M38.37%26.02M34.84%77.24M36.10%20.17M49.69%19.78M33.45%18.47M22.11%18.81M19.29%57.28M19.33%14.82M12.23%13.22M
Research and development costs 17.45%114.25M34.09%101.2M69.50%360.92M41.78%93.65M95.54%94.52M102.82%97.27M49.23%75.47M32.87%212.93M27.43%66.06M14.40%48.34M
Operating profit -13.84%-131.76M-34.94%-127.22M-62.15%-438.15M-40.73%-113.83M-85.70%-114.3M-87.29%-115.74M-42.90%-94.28M-29.74%-270.21M-25.86%-80.88M-13.93%-61.55M
Net non-operating interest income expense -7.72%5.6M-11.74%6.34M-0.87%24.73M-17.79%6.89M-48.62%4.59M70.02%6.07M76.63%7.18M229.22%24.95M140.78%8.38M203.43%8.93M
Non-operating interest income -7.72%5.6M-11.74%6.34M-0.87%24.73M-17.79%6.89M-48.62%4.59M70.02%6.07M76.63%7.18M229.22%24.95M140.78%8.38M203.43%8.93M
Other net income (expense) -60.25%250K4,139.29%1.19M103.49%471K141.40%1.07M-214.99%-1.26M3,045.00%629K100.23%28K-31.75%-13.51M-826.69%-2.59M109.31%1.09M
Special income (charges) ----------0--0--0--0--0-25.00%-12.5M--0--0
-Less:Restructuring and merger&acquisition ----------0--0--0--0--025.00%12.5M--0--0
-Less:Other special charges ----------------------------25.00%12.5M--0----
Other non- operating income (expenses) -60.25%250K4,139.29%1.19M146.73%471K141.40%1.07M-214.99%-1.26M3,045.00%629K-93.97%28K-298.42%-1.01M-826.69%-2.59M162.27%1.09M
Income before tax -15.47%-125.91M-37.47%-119.7M-59.58%-412.95M-40.99%-105.87M-115.37%-110.97M-87.33%-109.04M-17.75%-87.07M-22.67%-258.77M-24.27%-75.09M18.00%-51.53M
Income tax 661.54%594K1,085.71%913K57.14%891K151.29%583K240.74%152K-82.82%78K800.00%77K6,200.00%567K123.41%232K-127.91%-108K
Net income -15.93%-126.5M-38.40%-120.61M-59.58%-413.84M-41.33%-106.45M-116.11%-111.12M-86.01%-109.12M-17.87%-87.15M-22.93%-259.34M-26.73%-75.32M18.68%-51.42M
Net income continuous Operations -15.93%-126.5M-38.40%-120.61M-59.58%-413.84M-41.33%-106.45M-116.11%-111.12M-86.01%-109.12M-17.87%-87.15M-22.93%-259.34M-26.73%-75.32M18.68%-51.42M
Minority interest income
Net income attributable to the parent company -15.93%-126.5M-38.40%-120.61M-59.58%-413.84M-41.33%-106.45M-116.11%-111.12M-86.01%-109.12M-17.87%-87.15M-22.93%-259.34M-26.73%-75.32M18.68%-51.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -15.93%-126.5M-38.40%-120.61M-59.58%-413.84M-41.33%-106.45M-116.11%-111.12M-86.01%-109.12M-17.87%-87.15M-22.93%-259.34M-26.73%-75.32M18.68%-51.42M
Basic earnings per share 1.35%-0.73-18.33%-0.71-45.21%-2.73-23.08%-0.64-111.11%-0.76-64.44%-0.74-5.26%-0.6-9.94%-1.88-13.04%-0.5226.53%-0.36
Diluted earnings per share 1.35%-0.73-18.33%-0.71-45.21%-2.73-23.08%-0.64-111.11%-0.76-64.44%-0.74-5.26%-0.6-9.94%-1.88-13.04%-0.5226.53%-0.36
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More